Picture of Cardlytics logo

CDLX — Cardlytics News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMicro CapNeutral

Cardlytics Inc expected to post a loss of 55  cents a share - Earnings Preview

* Cardlytics Inc  CDLX.OQ   CDLX.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 2. 
    * The Atlanta Georgia-based  company is expected to report 
a
21.5% increase in revenue to $64.66 million from $53.23 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cardlytics Inc is
for a
loss of 55 cents per share. For the same quarter last year, the
company reported a loss of 34 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cardlytics
Inc is
$72​, above​ its last closing price of $34.13. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.36       -0.42      -0.15     Beat    63.9
 Sep. 30 2021  -0.52       -0.54      -0.33     Beat    38.9
 Jun. 30 2021  -0.38       -0.39      -0.39     Met     -0.9​
 Mar. 31 2021  -0.44       -0.34      -0.34     Met     -0.6
 ​​Dec.        -0.04       -0.03      -0.05     Missed  -92.3
 31 2020                                                
 Sep. 30 2020  -0.28       -0.28      -0.16     Beat    42.9​
 Jun. 30 2020  -0.45       -0.47      -0.38     Beat    19.8
 Mar. 31 2020  -0.22       -0.21      -0.26     Missed  -21.9
 This summary was machine generated April 30 at 02:06 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Cardlytics

See all news